Cresp Onco 200 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Darbepoetin alfa (200mcg)
Overview Cresp Onco 200 Injection
Cresp Onco 200 Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves stimulating red blood cell production within the bone marrow. This medication requires careful administration due to potential serious adverse effects; therefore, treatment should be overseen by a qualified specialist. Strict adherence to the physician's instructions is crucial. Administration occurs under direct medical supervision. Frequently reported side effects include abdominal discomfort, elevated blood pressure, skin rashes, injection site pain, dyspnea, coughing, and peripheral swelling. Report symptoms of significantly elevated blood pressure, such as intense headache, visual disturbances, nausea, vomiting, or convulsions, to your doctor immediately. Regular blood tests to monitor electrolyte (e.g., potassium) levels, hemoglobin, and blood cell counts are typically performed. Discontinue use and seek medical advice if shortness of breath or a skin rash develops. Prior to initiating Cresp Onco 200 Injection, inform your doctor of any pre-existing heart conditions, hypertension, seizure history, or stroke history. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals must consult their physician regarding its safety.
Uses of Cresp Onco 200 Injection
Managing anemia associated with chronic kidney disease | Addressing anemia resulting from cancer chemotherapy
Major Benefits of Cresp Onco 200 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cresp Onco 200 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Cresp Onco 200 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cresp Onco 200 Injection works:
Cresp Onco 200 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting increased red blood cell synthesis within the bone marrow, the blood cell-producing tissue inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Cresp Onco 200 Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cresp Onco 200 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the treatment's advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Cresp Onco 200 Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Cresp Onco 200 Injection.
KidneySAFE IF PRESCRIBED
Cresp Onco 200 Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
For individuals with hepatic impairment, administering Cresp Onco 200 Injection requires careful consideration. Dosage modification of Cresp Onco 200 Injection may be necessary. Physician consultation is advised.
What if you forget to take Cresp Onco 200 Injection :
Should you forget a Cresp Onco 200 Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cresp Onco 200 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Erythropoietin-stimulating drug |




